Analysts expect Envision Healthcare (NYSE:EVHC) to announce earnings of $0.90 per share for the current fiscal quarter, according to Zacks. Ten analysts have issued estimates for Envision Healthcare’s earnings. The lowest EPS estimate is $0.85 and the highest is $0.99. Envision Healthcare posted earnings of $0.85 per share in the same quarter last year, which would suggest a positive year over year growth rate of 5.9%. The firm is expected to report its next earnings report on Monday, August 6th.
On average, analysts expect that Envision Healthcare will report full-year earnings of $3.65 per share for the current financial year, with EPS estimates ranging from $3.60 to $3.75. For the next financial year, analysts expect that the firm will post earnings of $4.09 per share, with EPS estimates ranging from $3.77 to $4.36. Zacks’ EPS calculations are a mean average based on a survey of research analysts that follow Envision Healthcare.
Envision Healthcare (NYSE:EVHC) last issued its quarterly earnings results on Monday, May 7th. The company reported $0.71 EPS for the quarter, topping the consensus estimate of $0.64 by $0.07. Envision Healthcare had a net margin of 1.41% and a return on equity of 4.59%. The business had revenue of $2.08 billion for the quarter, compared to analysts’ expectations of $2.02 billion. During the same quarter last year, the company posted $0.77 earnings per share. The company’s quarterly revenue was up 10.6% compared to the same quarter last year.
Large investors have recently made changes to their positions in the business. BlackRock Inc. increased its stake in shares of Envision Healthcare by 6.5% in the fourth quarter. BlackRock Inc. now owns 8,028,329 shares of the company’s stock valued at $277,462,000 after purchasing an additional 487,314 shares during the period. Ares Management LLC acquired a new stake in shares of Envision Healthcare in the fourth quarter valued at approximately $752,000. Investors Research Corp acquired a new stake in shares of Envision Healthcare in the fourth quarter valued at approximately $338,000. Swiss National Bank increased its stake in shares of Envision Healthcare by 2.1% in the fourth quarter. Swiss National Bank now owns 442,116 shares of the company’s stock valued at $15,280,000 after purchasing an additional 9,200 shares during the period. Finally, Quantitative Systematic Strategies LLC increased its stake in shares of Envision Healthcare by 17.9% in the fourth quarter. Quantitative Systematic Strategies LLC now owns 14,319 shares of the company’s stock valued at $495,000 after purchasing an additional 2,169 shares during the period.
Shares of Envision Healthcare traded up $0.36, hitting $43.57, during trading hours on Friday, Marketbeat Ratings reports. 1,217,484 shares of the company were exchanged, compared to its average volume of 2,746,506. The company has a debt-to-equity ratio of 0.65, a quick ratio of 2.25 and a current ratio of 2.27. Envision Healthcare has a one year low of $23.77 and a one year high of $64.00. The stock has a market capitalization of $5.28 billion, a price-to-earnings ratio of 17.57, a PEG ratio of 0.99 and a beta of 0.43.
About Envision Healthcare
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.